Aprea Therapeutics, Inc. (APRE)
0.9199
+0.04
(+4.45%)
USD |
NASDAQ |
May 08, 10:42
Aprea Therapeutics Research and Development Expense (Annual) : 7.043M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Modular Medical, Inc. | 14.70M |
| Ernexa Therapeutics, Inc. | 4.156M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Tango Therapeutics, Inc. | 129.88M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |